SLC3A2 and acute myeloid leukemia: CD98 in primary AML cells is overexpressed in more than 90% of AML patients (Hayes et al., 2015), and its expression was 3-fold higher in AML CD34+ cells than healthy cells (Bajaj et al., 2016).